Go to Page # Page of 5
loading

Continuous subcutaneous insulin infusion for the treatment of diabetes

 NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE
  17th-Oct-2008
Description: Continuous subcutaneous insulin infusion (CSII) devices store and deliver short-acting insulin at a programmable quantity and rate. The CSII device connects to the patient via a catheter which is fitted to a needle or cannula inserted just under the skin. Several models are commercially available...
Views: 1520
Domain: Medical
Category: Biotech/Pharma
Contents:
Appendix NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE Health Technology Appraisal Continuous subcutaneous insulin infusion for the treatment of diabetes (review) Final scope Appraisal objective To review and update as necessary guidance to the NHS in England and Wales on the clinical and cost effectiveness of continuous subcutaneous insulin infusion for the treatment of diabetes, 1 which ... See more
...
18 September, 2008